Moll Apolonia, Lara Mónica, Pomar Jaume, Orozco Mónica, Frontera Guiem, Llompart-Pou Juan A, Moratinos Lesmes, González Víctor, Ibáñez Javier, Pérez-Bárcena Jon
Radiology Department.
Neurosurgical Department, Son Espases Hospital.
Medicine (Baltimore). 2020 Oct 23;99(43):e22879. doi: 10.1097/MD.0000000000022879.
Cerebral edema is a frequent and serious complication in traumatic brain injury (TBI) patients. The objective is to study the effect of dexamethasone in patients with brain contusions, and to assess its effect on the vasogenic component of the pericontusional edema.Prospective-observational study to quantify, using magnetic resonance imaging, the volume of the edema before and after 10 days of dexamethasone in patients with brain contusions. Using diffusion tensor imaging, we have examined the effect of dexamethasone on fractional anisotropy (FA) and apparent diffusion coefficient (ADC). To assess changes, the pre- and post-treatment values for each patient were compared using a paired-samples Student t test.We included 30 TBI patients, 15 in each group. The volume of the vasogenic edema in the group of patients treated with dexamethasone decreased from 22 to 19 mL and this decrease was statistically significant (P < .05). Nevertheless, in the non-steroids group the volume of the vasogenic edema increased from 11 to 15 mL. There was a significant decrease in the ADC value (from 1.78-1.59; P < .05); and a significant increase in the FA value (0.09-0.11; P < .05) in the patients treated with dexamethasone.Using diffusion tensor imaging we have shown in a selected group of TBI patients with vasogenic pericontusional edema, a reduction of edema volume, a decrease in the ADC and an increase in the FA after treatment with dexamethasone. However, we have no data if such results are beneficial in terms of improving functional outcome.
脑水肿是创伤性脑损伤(TBI)患者常见且严重的并发症。目的是研究地塞米松对脑挫裂伤患者的影响,并评估其对挫伤周围水肿血管源性成分的作用。
一项前瞻性观察研究,通过磁共振成像量化脑挫裂伤患者使用地塞米松10天前后的水肿体积。利用扩散张量成像,我们研究了地塞米松对分数各向异性(FA)和表观扩散系数(ADC)的影响。为评估变化情况,使用配对样本t检验比较每位患者治疗前后的值。
我们纳入了30例TBI患者,每组15例。地塞米松治疗组的血管源性水肿体积从22毫升降至19毫升,这种下降具有统计学意义(P<0.05)。然而,非类固醇组的血管源性水肿体积从11毫升增加至15毫升。地塞米松治疗的患者ADC值显著降低(从1.78降至1.59;P<0.05);FA值显著升高(从0.09升至0.11;P<0.05)。
利用扩散张量成像,我们在一组选定的伴有血管源性挫伤周围水肿的TBI患者中发现,地塞米松治疗后水肿体积减小,ADC降低,FA升高。然而,我们没有数据表明这些结果在改善功能结局方面是否有益。